002107 深市 沃华医药

证券代码：002107                              证券简称：沃华医药                          公告编号：2020-052
    山东沃华医药科技股份有限公司

              2020 年第三季度报告正文


                      第一节 重要提示

    公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。

    所有董事均已出席了审议本次季报的董事会会议。

    公司负责人赵丙贤、主管会计工作负责人王炯及会计机构负责人(会计主管人员)王炯声明：保证季度报告中财务报表的真实、准确、完整。


                    第二节 公司基本情况

一、主要会计数据和财务指标
公司是否需追溯调整或重述以前年度会计数据
□ 是 √ 否

                                      本报告期末              上年度末        本报告期末比上年度末增减

 总资产（元）                              1,428,640,425.19          1,008,021,813.82                  41.73%

 归属于上市公司股东的净资产（元）          769,283,173.77            671,978,183.94                  14.48%

                                    本报告期    本报告期比上年同期  年初至报告期末  年初至报告期末比上
                                                        增减                              年同期增减

 营业收入（元）                    266,709,489.26            19.01%      750,509,016.76            16.91%

 归属于上市公司股东的净利润（元）    50,031,655.80            142.43%      140,764,542.46            171.17%

 归属于上市公司股东的扣除非经常

 性损益的净利润（元）                49,078,218.92            151.54%      132,340,787.44            167.59%

 经营活动产生的现金流量净额（元）    55,495,727.91            20.22%      126,986,866.65            45.61%

 基本每股收益（元/股）                      0.09            125.00%                0.24            166.67%

 稀释每股收益（元/股）                      0.09            125.00%                0.24            166.67%

 加权平均净资产收益率                      6.72%              3.49%            19.47%            11.04%

非经常性损益项目和金额
√ 适用 □ 不适用

                                                                                                  单位：元

                        项目                          年初至报告期期末金额              说明

 非流动资产处置损益（包括已计提资产减值准备的冲销部分）            6,845,980.20

 计入当期损益的政府补助（与企业业务密切相关，按照国家统

 一标准定额或定量享受的政府补助除外）                              3,739,794.92

 债务重组损益                                                        404,800.00

 除上述各项之外的其他营业外收入和支出                              -1,940,439. 11

 其他符合非经常性损益定义的损益项目                                    3,903.12

 减：所得税影响额                                                    311,169.19

    少数股东权益影响额（税后）                                      319,114.92

 合计                                                              8,423,755.02            --

对公司根据《公开发行证券的公司信息披露解释性公告第 1 号——非经常性损益》定义界定的非经常性损益项目，以及把《公开发行证券的公司信息披露解释性公告第 1 号——非经常性损益》中列举的非经常性损益项目界定为经常性损益的项目，应说明原因

□ 适用 √ 不适用
公司报告期不存在将根据《公开发行证券的公司信息披露解释性公告第 1 号——非经常性损益》定义、列举的非经常性损益项目界定为经常性损益的项目的情形。
二、报告期末股东总数及前十名股东持股情况表
1、普通股股东和表决权恢复的优先股股东总数及前 10名股东持股情况表

                                                                                                  单位：股

 报告期末普通股股东总数                              报告期末表决权恢复的优先

 （户）                                        45,860 股股东总数（户）（如有）                            0

                                          前 10 名股东持股情况

                                                            持有有限售条件        质押或冻结情况

  股东名称      股东性质      持股比例      持股数量      的股份数量

                                                                              股份状态        数量

 北京中证万融投 境内非国有法人

 资集团有限公司                        50.27%    290,146,363

 张戈          境内自然人              1.74%      10,058,753      7,544,065

 赵军          境内自然人              1.45%      8,346,935      6,260,201

 林美惠        境内自然人              0.78%      4,501,300

 刘增          境内自然人              0.61%      3,499,680

 张法忠        境内自然人              0.60%      3,445,675

 谢玉玲        境内自然人              0.39%      2,259,111

 冯碧群        境内自然人              0.30%      1,743,181

 吴经琴        境内自然人              0.29%      1,647,360

 罗芝文        境内自然人              0.24%      1,402,120

                                      前 10 名无限售条件股东持股情况

                                                                                      股份种类

          股东名称                      持有无限售条件股份数量

                                                                              股份种类        数量

 北京中证万融投资集团有限公司                                    290,146,363 人民币普通股      290,146,363

 林美惠                                                            4,501,300 人民币普通股        4,501,300

 刘增                                                              3,499,680 人民币普通股        3,499,680

 张法忠                                                            3,445,675 人民币普通股        3,445,675

 张戈                                                              2,514,688 人民币普通股        2,514,688

 谢玉玲                                                            2,259,111 人民币普通股        2,259,111

 赵军                                                              2,086,734 人民币普通股        2,086,734

 冯碧群                                                            1,743,181 人民币普通股        1,743,181

 吴经琴                                                            1,647,360 人民币普通股        1,647,360


 罗芝文                                                            1,402,120 人民币普